Abstract
A dosimetric analysis has been performed to evaluate the potential of liposome systems as carriers of radionuclides in internal radiotherapy. Methods: Pharmacokinetic data for a variety of liposome constructs (multilamellar vesicles [MLV]; small unilamellar vesicles [SUV]; and sterically stabilized liposomes, monosialoganglioside [GM1]-coated) were used to obtain tumor and normal-organ absorbed dose estimates for 67Cu, 188Re, 90Y, and 131I.
Original language | English |
---|---|
Pages (from-to) | 499-504 |
Journal | The journal of Nuclear Medicine |
Volume | 42 |
Issue number | 3 |
Publication status | Published - 2001 |